source
- EGFR-Mutated NSCLC: Molecular Reassessment at Disease ProgressionIn this case-based segment, Dr. Sands presents a patient with EGFR-mutated metastatic non-small cell lung cancer who has progressed after first-line combination therapy with an EGFR tyrosine kinase…onclive · 2mo ago↗ source
- New Understandings of Treatments, End Points, and Disease Biology Expand MCL HorizonsLore Gruenbaum, PhD, discusses the direction mantle cell lymphoma is headed in addition to other critical areas of unmet needs.onclive · 2mo ago↗ source
- Cytokinetics succeeds where Bristol Myers failed in heart muscle diseaseCytokinetics’ pill for a heart muscle disorder called hypertrophic cardiomyopathy could see its addressable market double after it succeeded in a pivotal trial for another form of the disease. The…